Intuitive Surgical, Inc. (ISRG)
NASDAQ$493.6+29.98 (6.47%)
Market Cap
$166.1B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
636 of 893
Rank in Industry
32 of 46
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $75M | ||
| $60M | ||
| $56M |
ISRG Insider Trading Activity
ISRG Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $97,876,128 | 74 | 100 |
Related Transactions
| Ladd Amy L | director | 0 | $0 | 2 | $305,616 | $-305,616 |
| Widman Fredrik | VP Corporate Controller | 0 | $0 | 1 | $464,762 | $-464,762 |
| RUBASH MARK J | director | 0 | $0 | 1 | $649,420 | $-649,420 |
| LEVY ALAN J | director | 0 | $0 | 1 | $741,398 | $-741,398 |
| LOEB GARY | General Counsel | 0 | $0 | 2 | $901,427 | $-901,427 |
| BARRATT CRAIG H | director | 0 | $0 | 4 | $2.25M | $-2.25M |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | 0 | $0 | 15 | $2.81M | $-2.81M |
| Johnson Amal M | director | 0 | $0 | 2 | $3.93M | $-3.93M |
| DeSantis Robert | EVP & Chief Strategy & Corp Op | 0 | $0 | 21 | $6.18M | $-6.18M |
| Curet Myriam | EVP & Chief Medical Officer | 0 | $0 | 6 | $7.75M | $-7.75M |
| Miller Brian Edward | EVP & Chief Digital Officer | 0 | $0 | 4 | $7.91M | $-7.91M |
| Rosa David J. | President | 0 | $0 | 1 | $9.2M | $-9.2M |
| Charlton Henry L | SVP & Chief Commercial and Mkt | 0 | $0 | 2 | $11.91M | $-11.91M |
| Samath Jamie | See Remarks | 0 | $0 | 10 | $16.12M | $-16.12M |
| GUTHART GARY S | CEO | 0 | $0 | 2 | $26.76M | $-26.76M |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core …
Insider Activity of Intuitive Surgical, Inc.
Over the last 12 months, insiders at Intuitive Surgical, Inc. have bought $0 and sold $97.88M worth of Intuitive Surgical, Inc. stock.
On average, over the past 5 years, insiders at Intuitive Surgical, Inc. have bought $0 and sold $101.15M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $500,373 was made by Johnson Amal M (director) on 2010‑11‑19.
List of Insider Buy and Sell Transactions, Intuitive Surgical, Inc.
| 2025-03-13 | Sale | DeSantis Robert | EVP & Chief Strategy & Corp Op | 8,828 0.0026% | $499.38 | $4.41M | +3.33% | |
| 2025-03-12 | Sale | Miller Brian Edward | EVP & Chief Digital Officer | 2,450 0.0007% | $512.06 | $1.25M | -1.01% | |
| 2025-03-11 | Sale | Miller Brian Edward | EVP & Chief Digital Officer | 8,900 0.0025% | $485.07 | $4.32M | -0.25% | |
| 2025-03-07 | Sale | Brosius Mark | SVP & Chief Mfg and Supply Cha | 489 0.0001% | $533.18 | $260,725 | -4.97% | |
| 2025-03-06 | Sale | Brosius Mark | SVP & Chief Mfg and Supply Cha | 492 0.0001% | $558.95 | $275,003 | -8.41% | |
| 2025-03-05 | Sale | Rosa David J. | President | 16,509 0.0045% | $557.52 | $9.2M | -13.08% | |
| 2025-03-05 | Sale | Brosius Mark | SVP & Chief Mfg and Supply Cha | 492 0.0001% | $554.17 | $272,652 | -13.08% | |
| 2025-03-04 | Sale | Brosius Mark | SVP & Chief Mfg and Supply Cha | 492 0.0001% | $563.69 | $277,335 | -11.37% | |
| 2025-03-03 | Sale | Brosius Mark | SVP & Chief Mfg and Supply Cha | 492 0.0001% | $573.78 | $282,300 | -12.65% | |
| 2025-03-03 | Sale | Widman Fredrik | VP Corporate Controller | 810 0.0002% | $573.78 | $464,762 | -12.65% | |
| 2025-03-03 | Sale | Curet Myriam | EVP & Chief Medical Officer | 3,031 0.0009% | $577.30 | $1.75M | -12.65% | |
| 2025-02-28 | Sale | Samath Jamie | EVP & CFO & Enterprise Technol | 94 <0.0001% | $566.94 | $53,292 | -13.49% | |
| 2025-02-27 | Sale | Curet Myriam | EVP & Chief Medical Officer | 2,401 0.0007% | $581.00 | $1.39M | -11.96% | |
| 2025-02-26 | Sale | Samath Jamie | EVP & CFO & Enterprise Technol | 54 <0.0001% | $570.85 | $30,826 | -14.64% | |
| 2025-02-12 | Sale | LOEB GARY | EVP & Chief Legal and Complian | 1,300 0.0004% | $583.79 | $758,927 | -13.84% | |
| 2025-02-11 | Sale | Curet Myriam | EVP & Chief Medical Officer | 408 0.0001% | $589.75 | $240,618 | -13.71% | |
| 2025-02-10 | Sale | Samath Jamie | EVP & CFO & Enterprise Technol | 135 <0.0001% | $590.00 | $79,650 | -14.55% | |
| 2025-01-29 | Sale | Samath Jamie | EVP & CFO & Enterprise Technol | 94 <0.0001% | $571.11 | $53,684 | -2.58% | |
| 2025-01-28 | Sale | Johnson Amal M | director | 4,635 0.0013% | $566.60 | $2.63M | -2.31% | |
| 2025-01-28 | Sale | Samath Jamie | EVP & CFO & Enterprise Technol | 6,221 0.0017% | $574.87 | $3.58M | -2.31% |
Total: 748
*Gray background shows transactions not older than one year
Insider Historical Profitability
29.94%
| Johnson Amal M | director | 12275 0.0034% | $5.69M | 2 | 20 | +29.94% |
*Gray background shows insiders who have made transactions during last year
ISRG Institutional Investors: Active Positions
| Increased Positions | 1,102 | +58.55% | 13M | +4.41% |
| Decreased Positions | 787 | -41.82% | 11M | -3.59% |
| New Positions | 278 | New | 3M | New |
| Sold Out Positions | 81 | Sold Out | 805,448 | Sold Out |
| Total Postitions | 2,197 | +16.74% | 303M | +0.82% |
ISRG Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $14.55M | 9% | 32.21M | +360,591 | +1.13% | 2024-12-31 |
| Blackrock, Inc. | $14.17M | 8.77% | 31.38M | +1M | +3.93% | 2024-12-31 |
| State Street Corp | $6.91M | 4.28% | 15.31M | +255,304 | +1.7% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $6.53M | 4.04% | 14.47M | -125,824 | -0.86% | 2024-12-31 |
| Fmr Llc | $4.89M | 3.02% | 10.82M | -148,861 | -1.36% | 2024-12-31 |
| Jpmorgan Chase & Co | $4.58M | 2.84% | 10.15M | +150,417 | +1.5% | 2024-12-31 |
| Geode Capital Management, Llc | $3.5M | 2.17% | 7.76M | +243,802 | +3.25% | 2024-12-31 |
| Capital World Investors | $3.35M | 2.07% | 7.43M | +11,929 | +0.16% | 2024-12-31 |
| Morgan Stanley | $2.63M | 1.63% | 5.82M | +235,889 | +4.23% | 2024-12-31 |
| Bank Of New York Mellon Corp | $2.3M | 1.43% | 5.1M | -286,316 | -5.31% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Price to Earnings
Price/Earnings to Growth
Price to Sales
Price to Book
Price/Free Cash Flow
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.